Market News / Story
X4 Pharmaceuticals Secures Up to $150 Million Term Loan From K2 HealthVentures; $80 Million Funded
·
X4 Pharmaceuticals entered a new secured term loan facility of up to $150 million with K2 HealthVentures, funding $80 million at closing to refinance existing debt and support operations and growth. Concurrently, the company repaid and terminated its Hercules facility with a total payoff of approximately $78.7 million, releasing associated liens. The new loans carry cash interest at the greater of 8.55% or prime plus 1.55%, plus 1% PIK, feature interest-only payments…